Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cancer diagnostics and biomarker developer Epistem plans to use novel preclinical models for cutaneous wound healing developed by a University of Manchester scientist under a partnership that is supported by a UK government business development program.

Epistem said the partnership, which has been awarded a Knowledge Transfer Partnership from the Technology Strategy Board and the Medical Research Council, will enable the Manchester-based company to expand its range of wound healing models.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.